Litcius/Paper detail

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium

Amar U. Kishan, Yilun Sun, Alison Tree, Emma Hall, David P. Dearnaley, Charles Catton, Himanshu R Lukka, Gregory R. Pond, W. Robert Lee, Howard M. Sandler, Felix Y. Feng, Paul L. Nguyen, Luca Incrocci, Wilma D. Heemsbergen, Floris J. Pos, Eric Horwitz, J.K. Wong, Karen E. Hoffman, Comron Hassanzadeh, Deborah A. Kuban, Stefano Arcangeli, Giuseppe Sanguineti, S. Supiot, G. Créhange, I. Latorzeff, Tahmineh Romero Kalbasi, Michael L. Steinberg, Luca Valle, Andrew Loblaw, John Nikitas, Soumyajit Roy, Nicholas G. Zaorsky, Angela Y. Jia, Daniel E. Spratt

2025The Lancet Oncology19 citationsDOIOpen Access PDF

Topics & Concepts

Prostate cancerMedicineLernaean HydraMeta-analysisRadiation therapyOncologyCancerInternal medicineBiologyCell biologyProstate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesProstate Cancer Treatment and Research